160 related articles for article (PubMed ID: 19816786)
21. Health Related Quality of Life assessment among early-treated Hungarian adult PKU patients using the PKU-QOL adult questionnaire.
Barta AG; Sumánszki C; Turgonyi Z; Kiss E; Simon E; Serfőző C; Reismann P
Mol Genet Metab Rep; 2020 Jun; 23():100589. PubMed ID: 32346514
[TBL] [Abstract][Full Text] [Related]
22. [Assessment of the life quality in children with phenylketonuria].
Bushueva TV; Vinyarskaya IV; Chernikov VV; Borovik TE; Kuzenkova LM
Vestn Ross Akad Med Nauk; 2014; (11-12):39-45. PubMed ID: 25971125
[TBL] [Abstract][Full Text] [Related]
23. Body composition in children with galactosaemia.
Panis B; Forget PP; Nieman FH; van Kroonenburgh MJ; Rubio-Gozalbo ME
J Inherit Metab Dis; 2005; 28(6):931-7. PubMed ID: 16435185
[TBL] [Abstract][Full Text] [Related]
24. Phenylketonuria patients' and their parents' acceptance of the disease: multi-centre study.
Witalis E; Mikoluc B; Motkowski R; Szyszko J; Chrobot A; Didycz B; Lange A; Mozrzymas R; Milanowski A; Nowacka M; Piotrowska-Depta M; Romanowska H; Starostecka E; Wierzba J; Skorniewska M; Wojcicka-Bartlomiejczyk BI; Gizewska M;
Qual Life Res; 2016 Nov; 25(11):2967-2975. PubMed ID: 27245777
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents.
Thimm E; Schmidt LE; Heldt K; Spiekerkoetter U
J Inherit Metab Dis; 2013 Sep; 36(5):767-72. PubMed ID: 23296365
[TBL] [Abstract][Full Text] [Related]
26. Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal.
Landolt MA; Nuoffer JM; Steinmann B; Superti-Furga A
J Pediatr; 2002 May; 140(5):516-21. PubMed ID: 12032515
[TBL] [Abstract][Full Text] [Related]
27. Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine.
Palermo L; MacDonald A; Limback E; Robertson L; Howe S; Geberhiwot T; Romani C
J Clin Exp Neuropsychol; 2020 Mar; 42(2):142-159. PubMed ID: 31790339
[No Abstract] [Full Text] [Related]
28. The neuropsychological profile of galactosaemia.
Doyle CM; Channon S; Orlowska D; Lee PJ
J Inherit Metab Dis; 2010 Oct; 33(5):603-9. PubMed ID: 20607611
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+, K+, -ATPase and Mg2+ -ATPase activities induced by the in vitro galactosaemia.
Tsakiris S; Schulpis KH; Marinou K; Behrakis P
Pharmacol Res; 2004 May; 49(5):475-9. PubMed ID: 14998558
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
[TBL] [Abstract][Full Text] [Related]
31. Quality of life, developmental milestones, and self-esteem of young adults with congenital hypothyroidism diagnosed by neonatal screening.
van der Sluijs Veer L; Kempers MJ; Last BF; Vulsma T; Grootenhuis MA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2654-61. PubMed ID: 18460566
[TBL] [Abstract][Full Text] [Related]
32. Social outcome in treated individuals with inherited metabolic disorders: UK study.
Bhat M; Haase C; Lee PJ
J Inherit Metab Dis; 2005; 28(6):825-30. PubMed ID: 16435174
[TBL] [Abstract][Full Text] [Related]
33. Newborn screening for galactosaemia.
Lak R; Yazdizadeh B; Davari M; Nouhi M; Kelishadi R
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012272. PubMed ID: 29274129
[TBL] [Abstract][Full Text] [Related]
34. Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis.
Maratha A; Stockmann H; Coss KP; Estela Rubio-Gozalbo M; Knerr I; Fitzgibbon M; McVeigh TP; Foley P; Moss C; Colhoun HO; van Erven B; Stephens K; Doran P; Rudd P; Treacy E
Eur J Hum Genet; 2016 Jul; 24(7):976-84. PubMed ID: 26733289
[TBL] [Abstract][Full Text] [Related]
35. Classical galactosaemia revisited.
Bosch AM
J Inherit Metab Dis; 2006 Aug; 29(4):516-25. PubMed ID: 16838075
[TBL] [Abstract][Full Text] [Related]
36. Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria.
Cazzorla C; Cegolon L; Burlina AP; Celato A; Massa P; Giordano L; Polo G; Daniele A; Salvatore F; Burlina AB
BMC Public Health; 2014 Dec; 14():1243. PubMed ID: 25471331
[TBL] [Abstract][Full Text] [Related]
37. Correlates of language impairment in children with galactosaemia.
Potter NL; Lazarus JA; Johnson JM; Steiner RD; Shriberg LD
J Inherit Metab Dis; 2008 Aug; 31(4):524-32. PubMed ID: 18649009
[TBL] [Abstract][Full Text] [Related]
38. Dietary intake and nutritional status of patients with phenylketonuria in Taiwan.
Weng HL; Yang FJ; Chen PR; Hwu WL; Lee NC; Chien YH
Sci Rep; 2020 Sep; 10(1):14537. PubMed ID: 32883979
[TBL] [Abstract][Full Text] [Related]
39. Should newborn mutation scanning for hyperphenylalaninaemia and galactosaemia be implemented? A Polish experience.
Zekanowski C; Nowacka M; Radomyska B; Cabalska B
J Med Screen; 2001; 8(3):132-6. PubMed ID: 11678552
[TBL] [Abstract][Full Text] [Related]
40. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence.
Enns GM; Koch R; Brumm V; Blakely E; Suter R; Jurecki E
Mol Genet Metab; 2010; 101(2-3):99-109. PubMed ID: 20678948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
